The folate hydrolase 1561c>t polymorphism is associated with depressive symptoms in puerto Rican adults

Psychosomatic Medicine

Volumn 73, Issue 5, 2011, Pages 385-392

  Ye, Xingwang ^a,b   Lai, Chao Qiang ^b   Crott, Jimmy W ^b   Troen, Aron M ^b   Ordovas, Jose M ^b   Tucker, Katherine L ^a,b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

depressive symptoms; folate; folate hydrolase; genetics; glutamate carboxypeptidase II; polymorphisms

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLYLPOLYGLUTAMATE SYNTHASE; GAMMA GLUTAMYL HYDROLASE; HOMOCYSTEINE; METHIONINE SYNTHASE; PROTON COUPLED FOLATE TRANSPORTER; REDUCED FOLATE CARRIER;

ACADEMIC ACHIEVEMENT; ADULT; AGED; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUERTO RICO; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 79958158233     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31821a1ab4     Document Type: Article

References (47)

1. Reynolds EH, Preece JM, Bailey J, Coppen A. Folate deficiency in depressive illness. Br J Psychiatry 1970;117:287-92.
2. Abou-Saleh MT, Coppen A. The biology of folate in depression: implications for nutritional hypotheses of the psychoses. J Psychiatr Res 1986; 20:91-101. (Pubitemid 16061432)
3. Abou-Saleh MT, Coppen A. Serum and red blood cell folate in depression. Acta Psychiatr Scand 1989;80:78-82. (Pubitemid 19179480)
4. Guaraldi GP, Fava M, Mazzi F, la Greca P. An open trial of methylte-trahydrofolate in elderly depressed patients. Ann Clin Psychiatry 1993;5: 101-5. (Pubitemid 23210906)
5. Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990;336:392-5. (Pubitemid 20252436)
6. 12 and homocysteine levels in late-life depression. Br J Psychiatry 2008;192:268-74. (Pubitemid 351692399)
7. Skarupski KA, Tangney C, Li H, Ouyang B, Evans DA, Morris MC. Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am J Clin Nutr 2010;92:330-5.
8. 6 is associated with depressive symptomatology in Massachusetts elders. J Am Coll Nutr 2008;27: 421-7.
9. Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000;157:715-21. (Pubitemid 30249649)
10. 12, C and folate concentrations in the New Mexico elder health survey: correlations with cognitive and affective functions. J Am Coll Nutr 2000;19:68-76. (Pubitemid 30090447)
11. Kamphuis MH, Geerlings MI, Grobbee DE, Kromhout D. Dietary intake of B(6-9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study. Eur J Clin Nutr 2008;62:939-45.
12. Nguyen PH, Grajeda R, Melgar P, Marcinkevage J, DiGirolamo AM, Flores R, Martorell R. Micronutrient supplementation may reduce symptoms of depression in Guatemalan women. Arch Latinoam Nutr 2009;59: 278-86.
13. Beydoun MA, Shroff MR, Beydoun HA, Zonderman AB. Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults. Psychosom Med 2010;72:862-73.
14. Van Praag HM. Depression. Lancet 1982;2:1259-64. (Pubitemid 13240866)
15. Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademe-tionine (S-adenosylmethionine) in neurological disorders. Drugs 1994;48: 137-52. (Pubitemid 24260350)
16. Hillemacher T, Frieling H, Muschler MA, Bleich S. Homocysteine and epigenetic DNA methylation: a biological model for depression? Am J Psychiatry 2007;164:1610. (Pubitemid 350069742)
17. 12, homocysteine, and the MTHFR 677C-9T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003;60:618-26. (Pubitemid 36682319)
18. Kelly CB, McDonnell AP, Johnston TG, Mulholland C, Cooper SJ, McMaster D, Evans A, Whitehead AS. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol 2004;18:567-71. (Pubitemid 39665125)
19. Gaysina D, Cohen S, Craddock N, Farmer A, Hoda F, Korszun A, Owen MJ, Craig IW, McGuffin P. No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2008;147B:699-706.
20. DeVos L, Chanson A, Liu Z, Ciappio ED, Parnell LD, Mason JB, Tucker KL, Crott JW. Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. Am J Clin Nutr 2008;88:1149-58.
21. Tucker KL, Mattei J, Noel SE, Collado BM, Mendez J, Nelson J, Griffith J, Ordovas JM, Falcon LM. The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities. BMC Public Health 2010;10:107.
22. Mahard RE. The CES-D as a measure of depressive mood in the elderly Puerto Rican population. J Gerontol 1988;43:P24-P5.
23. Robison J, Gruman C, Gaztambide S, Blank K. Screening for depression in middle-aged and older Puerto Rican primary care patients. J Gerontol A Biol Sci Med Sci 2002;57:M308-14. (Pubitemid 34464971)
24. Schrader G, Cheok F, Hordacre A-L, Guiver N. Predictors of depression three months after cardiac hospitalization. Psychosom Med 2004;66: 514-20. (Pubitemid 38971245)
25. Falcon LM, Tucker KL. Prevalence and correlates of depressive symptoms among Hispanic elders in Massachusetts. J Gerontol B Psychol Sci Soc Sci 2000;55:S108-16. (Pubitemid 30241712)
26. Gregory Warnes, with contributions from Gregor Gorjanc, Friedrich Leisch and Michael Man. Genetics: population genetics. R package version 1.3.4. 2008.
27. Lai CQ, Tucker KL, Choudhry S, Parnell LD, Mattei J, Garcia-Bailo B, Beckman K, Burchard EG, Ordovas JM. Population admixture associated with disease prevalence in the Boston Puerto Rican health study. Hum Genet 2009;125:199-209.
28. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005;95:221-7. (Pubitemid 43093236)
29. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004;74:765-9. (Pubitemid 38420107)
30. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-91.
31. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
32. Halsted CH, Wong DH, Peerson JM, Warden CH, Refsum H, Smith AD, Nygard OK, Ueland PM, Vollset SE, Tell GS. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. Am J Clin Nutr 2007;86:514-21. (Pubitemid 47256940)
33. Guilarte TR, Hammoud DA, McGlothan JL, Caffo BS, Foss CA, Kozikowski AP, Pomper MG. Dysregulation of glutamate carboxypeptidase II in psychiatric disease. Schizophr Res 2008;99:324-32.
34. Benarroch EE. N-acetylaspartate and N-acetylaspartylglutamate: neuro-biology and clinical significance. Neurology 2008;70:1353-7. (Pubitemid 351550340)
35. Neale JH, Olszewski RT, Gehl LM, Wroblewska B, Bzdega T. The neu-rotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol Sci 2005; 26:477-84. (Pubitemid 41207880)
36. Mauri MC, Ferrara A, Boscati L, Bravin S, Zamberlan F, Alecci M, Invernizzi G. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuro-psychobiology 1998;37:124-9. (Pubitemid 28171767)
37. Maes M, Verkerk R, Vandoolaeghe E, Lin A, Scharpe S. Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatr Scand 1998;97:302-8. (Pubitemid 28179268)
38. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82:442-50.
39. 6 status in women with postpartum depression. Am J Clin Nutr 1978;31:886-91. (Pubitemid 8348941)
40. Dakshinamurti K, Paulose CS, Viswanathan M, Siow YL, Sharma SK, Bolster B. Neurobiology of pyridoxine. Ann N Y Acad Sci 1990;585: 128-44. (Pubitemid 20175893)
41. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 2009;61:105-23.
42. Gorman JM, Kent JM. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. J Clin Psychiatry 1999;60(suppl 4):33-8; discussion 9.
43. 6 in clinical neurology. Ann N Y Acad Sci 1990;585:250-60. (Pubitemid 20175902)
44. Alamo C, Lopez-Munoz F. New antidepressant drugs: beyond mono-aminergic mechanisms. Curr Pharm Des 2009;15:1559-62.
45. Machado-Vieira R, Salvadore G, Ibrahim LA, Diaz-Granados N, Zarate CA Jr. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders. Curr Pharm Des 2009;15:1595-611.
46. Potter LB, Rogler LH, Moscicki EK. Depression among Puerto Ricans in New York City: the Hispanic Health and Nutrition Examination Survey. Soc Psychiatry Psychiatr Epidemiol 1995;30:185-93.
47. Santor DA, Coyne JC. Shortening the CES-D to improve its ability to detect cases of depression. Psychol Assess 1997;9:233-43. (Pubitemid 27428327)